NPC1-dependent alterations in K<sub>V</sub>2.1-Ca<sub>V</sub>1.2 nanodomains drive neuronal death in models of Niemann-Pick Type C disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37507375.
- Also identified by DOI 10.1038/s41467-023-39937-w and PMC identifier 10382591.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Lysosomes communicate through cholesterol transfer at endoplasmic reticulum (ER) contact sites. At these sites, the Niemann Pick C1 cholesterol transporter (NPC1) facilitates the removal of cholesterol from lysosomes, which is then transferred to the ER for distribution to other cell membranes. Mutations in NPC1 result in cholesterol buildup within lysosomes, leading to Niemann-Pick Type C (NPC) disease, a progressive and fatal neurodegenerative disorder. The molecular mechanisms connecting NPC1 loss to NPC-associated neuropathology remain unknown. Here we show both in vitro and in an animal model of NPC disease that the loss of NPC1 function alters the distribution and activity of voltage-gated calcium channels (Ca<sub>V</sub>). Underlying alterations in calcium channel localization and function are K<sub>V</sub>2.1 channels whose interactions drive calcium channel clustering to enhance calcium entry and fuel neurotoxic elevations in mitochondrial calcium. Targeted disruption of K<sub>V</sub>2-Ca<sub>V</sub> interactions rescues aberrant Ca<sub>V</sub>1.2 clustering, elevated mitochondrial calcium, and neurotoxicity in vitro. Our findings provide evidence that NPC is a nanostructural ion channel clustering disease, characterized by altered distribution and activity of ion channels at membrane contacts, which contribute to neurodegeneration.
Medical subject headings
- Niemann-Pick Disease, Type C